Quest Diagnostics Continuing Medical Education
Welcome to the Quest Diagnostics Continuing Medical Education (CME) page. Below are links to CME learning opportunities that are available to you with the permission of the accredited providers. Activities were selected, whether in part or in whole, for their appropriateness to the practice of clinical medicine.
Description: This webinar discusses evidence for the utility of natriuretic peptide testing to improve outcome, and presents case studies on the management of heart failure after admission and discharge.
This link is presented with permission from Medavera
CME Expiration Date: 11/29/2019
Description: Over the last few years, a number of innovative new treatment options for chronic hepatitis C virus (HCV) have become available, including several new direct-acting antiviral agents (DAAs). The emerging class of DAAs currently includes 3 NS3-4A protease inhibitors, 5 NS5A inhibitors, and 2 NS5B polymerase inhibitors, which are used in various combinations to treat the HCV genotypes 1-6. Learn how utilization of DAAs has dramatically advanced the standard of care for HCV, leading to enhanced efficacy, fewer side effects, and better outcomes for patients.
This link is presented with permission from Haymarket Medical Education
CME Expiration Date: 08/31/2018
For comments or suggestions, please email CME@QuestDiagnostics.com
These CME activities are provided for informational purposes only and are not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.